Chika Madu MD will oversee all radiation oncology clinical care, research, and training programs. He is a national leader in the field of radiation
In this interim analysis we looked at using a novel approach to spare critical erectile structures to preserve erectile function after prostate cancer radiotherapy. We…
Nature – An analysis of millions of scientific papers and patents reveals a ‘pivot penalty’ when researchers shift direction, with the impact of studies decreasing…
We have previously reported that radiotherapy (RT) added to androgen-deprivation therapy (ADT) improves survival in men with locally advanced prostate cancer. Here, we report the…
Within a prostate cancer screening context, is magnetic resonance imaging (MRI)-based screening more cost-effective than no screening and screening using prostate-specific antigen (PSA) alone? In…
To develop and validate an accurate, usable prediction model for other‐cause mortality (OCM) in patients with prostate cancer diagnosed in the United States. Model training…
Using genomic classifier scores, older men with low-risk prostate cancer were shown to harbor more aggressive disease than younger patients. This suggests that elderly patients…
The comparative effectiveness of treatments for prostate cancer that is detected by prostate-specific antigen (PSA) testing remains uncertain. We compared active monitoring, radical prostatectomy, …
This 2018 updated Recommendation Statement from the US Preventive Services Task Force concludes that clinicians should not screen for prostate cancer in men aged 55…
For Closed Captions:https://secure-web.cisco.com/1BXytnVDBbBM1fwxOYzMlCpjIdmaJhFVP-euR-j7Xs1BukyX1HBvZczvgu2cvcAsfv93jHU0MoqYCuGmsvpyCiEIWach3ZVzhU9k8N107L-2…
Improvement in prostate cancer (PCa) localization through multiparametric MRI (mpMRI) coupled with targeted biopsy has spurred interest in applying similar principles to address magnetic resonance…
